Key facts
- It has raised $13.6M; the latest was Later Stage VC ($6.3M) in Sep 2024.
- Notable investors include Entrepreneurs First, Refactor Capital, 1517 Fund, Knollwood Investment Advisory, California Innovation Fund — 9 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Miist Therapeutics
- ·The full record, as it builds
Funding rounds
No funding rounds for Miist Therapeutics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Miist Therapeutics
Developer of inhaled therapies designed to provide rapid symptom relief for patients. The company offers clinically validated treatments using aerosol physics to aid individuals in quitting smoking by providing instant-acting therapies, enabling individuals with migraines and those seeking smoking cessation to experience fast and effective relief.
- Sector
- Healthcare
- HQ
- Alameda, CA, United States
- Founded
- 2019
- Employees
- 8
- Website
- miisttherapeutics.com/
- Ownership
- Privately Held (backing)
Miist Therapeutics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Miist Therapeutics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Miist Therapeutics in its N-PORT filings yet. We sweep new filings monthly.